Table 2.

Pathological features and stages of the patients

	Breast-conserving surgery group (n = 41)	Oxidized regenerated cellulose group (n = 41)	Gelatin sponge group (n = 43)	P
Pathological pattern (n)				0.644
Invasive ductal carcinoma	38	36	40
Ductal carcinoma in situ	3	5	3
Tumor size (n)				0.916
Tis	3	5	3
T1	29	28	30
T2	9	8	10
Lymph node status (n)				0.866
N0	35	36	36
N1	6	5	7
Staging (n)
0	3	5	3	0.883
1A	26	25	28
2A	8	9	7
2B	4	2	5
ER status (n)				0.533
Positive	26	30	27
Negative	15	11	16
PR status (n)				0.736
Positive	25	22	23
Negative	16	19	20
HER-2 status (n)				0.752
Positive	8	5	10
Negative	33	36	33
Triple negative breast cancer (n)	8	7	9
Adjuvant chemotherapy (n)				0.877
Yes	30	28	31
No	11	13	12
Endocrine therapy (n)
Yes	29	34	32	0.415
No	12	7	11

Pearson chi-square test was used